CSI Market
Sign In | Register

Oxford Immunotec Global Plc (OXFD) Annual Cash Flow Statement

Annual · GAAP · USD millions
Access OXFD quarterly Cash Flow →
The quarterly cash flow data below helps track how Oxford Immunotec Global Plc's liquidity profile has evolved over recent quarters.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Annual Report, GAAP in USD millions
ITEM 		(Dec 31 2019)
12 Months 		(Dec 31 2018) (Dec 31 2017) (Dec 31 2016) (Dec 31 2015)
Operating Activities
Income-1.81
Depreciation & amortization0.00
Amortization of Other Assets0.00
Increase (Decrease) in Deferred Revenue-0.11
Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability0.00
Provision For Loan Losses Expensed0.00
Inventories Decrease /-Increase-2.83
R & D, Environmental and Other Expense0.00
Gain (Loss) on Disposition of Property Plant Equipment0.05
Share-based Compensation3.61
Income (Loss) from Equity Method Investments0.00
Fair Value Adjustment of Warrants0.00
Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest-1.34
Depreciation Depletion And Amortization Intangible Assets-
Noncash Rent Expense-
Noncash Interest-
Income taxes-0.04
Losses/ -gains on Investments net0.00
Increase (Decrease) in Accounts Receivable-4.26
Increase (Decrease) in Accounts Payable-0.36
Increase (Decrease) in Accrued Liabilities-5.09
Deferred Revenue and Customer Advances and Deposits0.00
Increase (Decrease) in Prepaid Expense and Other Assets1.39
Other Working Capital0.00
Other Noncash Income (Expense)0.00
Other net0.00
Payments for (Proceeds from) Other Operating Activities4.09
Discontinued operations-0.47
Net Cash flow from Operating Activities-7.16
Investing Activities
Capital Expenditures-1.66
Sale of Capital Items0.00
Short-term Investments Proceeds0.00
Short-term Investments Acq.0.00
Real Estate Investments0.00
Purchases Of Intangible Assets-
Increase (Decrease) in Restricted Cash0.00
Payments for (Proceeds from) Loans0.00
Payments for (Proceeds from) Deposits0.00
Payments for (Proceeds from) Other Investments0.00
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Payments to Acquire Businesses, Net of Cash Acquired0.00
Interest in Subsidiaries and Affiliates0.00
Sale of businesses0.00
Accounts payable0.00
Receivables0.00
Payments for (Proceeds from) Other Investing Activities0.00
Other Net0.00
Discontinued operations0.00
Net Cash Flow from Investing Activities-1.66
Financing Activities
Short-term debt Net0.00
Other borrowing transactions0.00
Long-term debt - borrowings0.00
Long-term debt - repayments0.00
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock-2.96
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock0.00
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net0.00
Other net-197.24
Proceeds From Exercise Of Share Options And Warrants-
Proceeds Received In Advance Of Share Issuance-
Line Of Credit Discount-
Loss On Extinguishment Of Debt-
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations192.94
Interest Received Paid Net4.07
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid0.00
Net Cash Flow from Financing Activities-3.18
Effect of exchange rate on cash flow0.43
Discontinued operations0.00
Free Cash Flow-8.82
Total Cash Flow-23.58
4 historic quarters locked

Sign in to unlock the full Oxford Immunotec Global Plc cash flow history.

Sign In Create Free Account

About OXFD Annual Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC 10-K filings and normalized by CSIMarket.

Source & verification

  • Form: 10-K
  • Filed with the SEC: n/a

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.

Figures are derived from filed reports and may be restated. Historical data is subject to revision.

Untitled Document 





                    


    



  Get the full CSIMarket dataset:
  Subscribe
  API
  License